SETDB2 Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA519436-Each-of-1 | In Stock | ₹ 46,502.50 |
PIPA519436 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,502.50
GST (18%): ₹ 8,370.45
Total Price: ₹ 54,872.95
Antigen
SETDB2
Classification
Polyclonal
Conjugate
Unconjugated
Gene
SETDB2
Gene Alias
bifurcated 2; C13orf4; Chronic lymphocytic leukemia deletion region gene 8 protein; Clld8; CLLL8; CLLL8 protein; DKFZp586I0123; DKFZp761J1217; Gm293; Histone-lysine N-methyltransferase SETDB2; KMT1F; Lysine N-methyltransferase 1F; SET domain; SET domain bifurcated 2; SET domain, bifurcated 2; Setdb2; Setdb2-Phf11-1-Phf11-2 fusion
Host Species
Rabbit
Purification Method
Antigen affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
83852
Content And Storage
-20°C or -80°C if preferred
Form
Liquid
Applications
Immunocytochemistry, Western Blot
Concentration
1 mg/mL
Formulation
PBS with 0.02% sodium azide; pH 7.4
Gene Accession No.
Q96T68
Gene Symbols
SETDB2
Immunogen
Synthetic peptide conjugated to KLH derived from within residues 550 - 650 of Human CLLD8/SETDB2.
Quantity
100 μg
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Isotype
IgG
Related Products
Description
- PA5-19436 targets CLLD8/SETDB2 in IHC (P) and WB applications and shows reactivity with Human samples
- The PA5-19436 immunogen is synthetic peptide conjugated to KLH derived from within residues 550 - 650 of Human CLLD8/SETDB2
- Proteins that contain a SET domain, such as SETDB2, modulate gene expression epigenetically through histone H3 methylation
- SETDB2 is likely a histone H3 methyltransferase, as it contains both the active site and flanking cysteine residues required for catalytic activity (Zhang et al., 2003 ).